Executive Snapshot

Figure: Executive Snapshot: European Life Sciences Key IT Deals and Initiatives Update, Q1 2022

Situation Overview

Expanding Pharma Beyond the Pill, Strengthening Patient Engagement

Digital Therapeutics

Medication Optimization and Treatment Compliance, Connected Drug Delivery Systems for Diabetes Management

Advancing Early Detection and Precision Diagnostics, Expanding Med Tech Innovation and Services

Supporting Screening and Early Detection of Diseases, Precision Diagnostics

Expanding Med Tech Services and Innovation

Digitizing Surgical Care, Precision Surgery

Connected Surgical Care

Robotic Surgery

Expediting R&D, Advancing Precision Medicine, Accelerating the Use of Real-World Data

AI-Enabled Drug Discovery and Design

At the Intersection of Healthcare and Life Sciences: Secondary Use of Health Data, Data-Driven Ecosystems, Research Collaboration at Scale

Supporting Trial Design and Execution, Enabling Decentralized Trials

Facilitating Trial Design, Patient Matching and Recruitment

Integrating Real-World Data

Supporting Decentralized and Hybrid Trials

End-to-End Trial Management

Transforming Pharmacovigilance

Digital Transformation Toward an Intelligent Life Sciences Enterprise

Mergers and Acquisitions

Supporting Innovation Acceleration

Advice for the Technology Buyer

Learn More

Related Research

Synopsis